Teva Pharmaceuticals Marc A. Goshko Memorial Grant
This grant supported innovative research in organic and medicinal chemistry with practical applications for developing human medicines.
This grant is no longer accepting proposals
American Chemical Society has archived this opportunity.
Funder: American Chemical Society
Due Dates: Program closed (last cycle: September 1, 2021–August 31, 2023)
Funding Amounts: $100,000/year for 3 years (total $300,000); 1 award per cycle
Summary: Supported innovative research in organic and medicinal chemistry by recently tenured US faculty, fostering advances relevant to human medicines.
Key Information: Program is no longer accepting new applications.
Description
The Teva Pharmaceuticals Marc A. Goshko Memorial Grant, administered by the American Chemical Society (ACS) and funded by Teva Pharmaceuticals, recognized and supported innovative academic research in organic and medicinal chemistry from 2009 to 2023. The grant aimed to foster projects with significant potential for practical impact in the discovery of organic compounds beneficial as human medicines. Emphasis was placed on scientific merit, creativity, novelty, and addressing unexplored areas within the field. Awardees were required to submit annual reports and present a lecture upon completing the grant.
